Metabolic Syndrome and Risk of Amyotrophic Lateral Sclerosis: Insights from a Large‐Scale Prospective Study
Annals of Neurology · 2024
DOI: 10.1002/ana.27019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2024. Verfasst von Junwei Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Metabolic Syndrome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Ethical Decision Committee of the Research Administration at First Affiliated Hospital of Wenzhou Medical University.
Abstract (Originalsprache)
Objective
Although metabolic abnormalities are implicated in the etiology of neurodegenerative diseases, their role in the development of amyotrophic lateral sclerosis (ALS) remains a subject of controversy. We aimed to identify the association between metabolic syndrome (MetS) and the risk of ALS.
Methods
This study included 395,987 participants from the UK Biobank to investigate the relationship between MetS and ALS. Cox regression model was used to estimate hazard ratios (HR). Stratified analyses were performed based on gender, body mass index (BMI), smoking status, and education level. Mediation analysis was conducted to explore potential mechanisms.
Results
In this study, a total of 539 cases of ALS were recorded after a median follow‐up of 13.7 years. Patients with MetS (defined harmonized) had a higher risk of developing ALS after adjusting for confounding factors (HR: 1.50, 95% CI: 1.19–1.89). Specifically, hypertension and high triglycerides were linked to a higher risk of ALS (HR: 1.53, 95% CI: 1.19–1.95; HR: 1.31, 95% CI: 1.06–1.61, respectively). Moreover, the quantity of metabolic abnormalities showed significant results. Stratified analysis revealed that these associations are particularly significant in individuals with a BMI
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Neurology, Peking University Third Hospital, Beijing, China.
- Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Disorders, Beijing, China.
- Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.
- Department of Neurology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Binbin Deng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Ethical Decision Committee of the Research Administration at First Affiliated Hospital of Wenzhou Medical University
Zitieren
APA
Zhang, J., Cao, W., Xie, J., Pang, C., Gao, L., Zhu, L., Li, Y., Yu, H., Du, L., Fan, D., & Deng, B. (2024). Metabolic Syndrome and Risk of Amyotrophic Lateral Sclerosis: Insights from a Large‐Scale Prospective Study. Annals of Neurology. https://doi.org/10.1002/ana.27019
Vancouver
Zhang J, Cao W, Xie J, Pang C, Gao L, Zhu L, et al. Metabolic Syndrome and Risk of Amyotrophic Lateral Sclerosis: Insights from a Large‐Scale Prospective Study. Annals of Neurology. 2024. doi:10.1002/ana.27019
BibTeX
@article{Zhang2024,
author = {Zhang, Junwei and Cao, Wen and Xie, Jiali and Pang, Chunyang and Gao, Lingfei and Zhu, Luyi and Li, Yaojia and Yu, Huan and Du, Lihuai and Fan, Dongsheng and Deng, Binbin},
title = {Metabolic Syndrome and Risk of Amyotrophic Lateral Sclerosis: Insights from a Large‐Scale Prospective Study},
journal = {Annals of Neurology},
year = {2024},
doi = {10.1002/ana.27019}
}
EUVIMED